Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products — United States, October 2024–February 2025
2025 · MMWR Morbidity and Mortality Weekly Report · 17 citations
https://doi.org/10.15585/mmwr.mm7416a1